Views & Analysis Bad behaviour: why understanding human behaviour can improve... Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour.
Views & Analysis Behaviour science: the new capability every pharma company s... Mark Lightowler takes a look at why medical interventions are evolving beyond drugs to also help patients change behaviours that impact their disease.
Views & Analysis How behavioural science is helping in the fight against COVI... Thanks to COVID-19, just about every form of media we consume right now is focused on aspects of changing how we live.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.